Clinical trial
Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+), inTunisia
NCT04351919 is registered in ClinicalTrials.gov with Abderrahmane Mami Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+), inTunisia
- Lead sponsor
- Abderrahmane Mami Hospital
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- May 5, 2020
- Completion date
- July 15, 2020
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
patients with covid19